Fig. 1
From: Clinical utility of serum biomarkers in Duchenne muscular dystrophy
Venn diagram showing overlapping and unique number of identified biomarkers by SomaScan and mass spectrometry based proteome profiling techniques. Both techniques combined identified and quantified 59 biomarkers in DMD sera samples. Biomarkers that were uniquely identified by mass spectrometry are mostly myofibrillar proteins for which there was no Somamer designed. Biomarkers that were uniquely identified by SomaScan are those that are below mass spectrometry detection limit